Gene · 1975
Papers2,047
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,047
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| In silico transcriptional analysis of asymptomatic and severe COVID-19 patients reveals the susceptibility of severe patients to other comorbidities and non-viral pathological conditions. | Hum Gene (Amst) | 2023 | 37521006 | PubTator, text mining | PubMed |
| mTOR Signaling Pathway and Gut Microbiota in Various Disorders: Mechanisms and Potential Drugs in Pharmacotherapy. | Int J Mol Sci | 2023 | 37511569 | PubTator, text mining | PubMed |
| A Role of PI3K/Akt Signaling in Oocyte Maturation and Early Embryo Development. | Cells | 2023 | 37508495 | PubTator, text mining | PubMed |
| CBF-Beta Mitigates PI3K-Alpha-Specific Inhibitor Killing through PIM1 in PIK3CA-Mutant Gastric Cancer. | Mol Cancer Res | 2023 | 37493631 | PubTator, text mining | PubMed |
| Pterostilbene induces apoptosis in hepatocellular carcinoma cells: Biochemical, pathological, and molecular markers. | Saudi J Biol Sci | 2023 | 37483838 | PubTator, text mining | PubMed |
| A systems biology approach to pathogenesis of gastric cancer: gene network modeling and pathway analysis. | BMC Gastroenterol | 2023 | 37482618 | PubTator, text mining | PubMed |
| Nicotinamide mononucleotide (NMN) alleviates the poly(I:C)-induced inflammatory response in human primary cell cultures. | Sci Rep | 2023 | 37474783 | PubTator, text mining | PubMed |
| MGCG regulates glioblastoma tumorigenicity via hnRNPK/ATG2A and promotes autophagy. | Cell Death Dis | 2023 | 37460467 | PubTator, text mining | PubMed |
| PPM1H is down-regulated by ATF6 and dephosphorylates p-RPS6KB1 to inhibit progression of hepatocellular carcinoma. | Mol Ther Nucleic Acids | 2023 | 37456776 | PubTator, text mining | PubMed |
| Advances in the protein‑encoding functions of circular RNAs associated with cancer (Review). | Oncol Rep | 2023 | 37449515 | PubTator, text mining | PubMed |
| The Implications of Cannabinoid-Induced Metabolic Dysregulation for Cellular Differentiation and Growth. | Int J Mol Sci | 2023 | 37446181 | PubTator, text mining | PubMed |
| The ribosomal protein S6 kinase alpha-1 (RPS6KA1) induces resistance to venetoclax/azacitidine in acute myeloid leukemia. | Leukemia | 2023 | 37414921 | PubTator, text mining | PubMed |
| Predicted Proteome Association Studies of Breast, Prostate, Ovarian, and Endometrial Cancers Implicate Plasma Protein Regulation in Cancer Susceptibility. | Cancer Epidemiol Biomarkers Prev | 2023 | 37409955 | PubTator, text mining | PubMed |
| Cotargeting a MYC/eIF4A-survival axis improves the efficacy of KRAS inhibitors in lung cancer. | J Clin Invest | 2023 | 37384411 | PubTator, text mining | PubMed |
| Biological insights in non-small cell lung cancer. | Cancer Biol Med | 2023 | 37381723 | PubTator, text mining | PubMed |
| Cancer metastasis under the magnifying glass of epigenetics and epitranscriptomics. | Cancer Metastasis Rev | 2023 | 37369946 | PubTator, text mining | PubMed |
| Backbone resonance assignments of the C-terminal region of human translation initiation factor eIF4B. | Biomol NMR Assign | 2023 | 37368134 | PubTator, text mining | PubMed |
| LncRNA MIR4435-2HG drives cancer progression by modulating cell cycle regulators and mTOR signaling in stroma-enriched subtypes of urothelial carcinoma of the bladder. | Cell Oncol (Dordr) | 2023 | 37355516 | PubTator, text mining | PubMed |
| Lactoferrin attenuates cardiac fibrosis and cardiac remodeling after myocardial infarction via inhibiting mTORC1/S6K signaling pathway. | Theranostics | 2023 | 37351157 | PubTator, text mining | PubMed |
| Integrated analyses delineate distinctive immunological pathways and diagnostic signatures for Behcet's disease by leveraging gene microarray data. | Immunol Res | 2023 | 37341899 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1975/papers?page=7